The potential role of microRNA-146 in Alzheimer's disease: Biomarker or therapeutic target?

Medical Hypotheses

Volumn 78, Issue 3, 2012, Pages 398-401

  Wang, Li Ling ^a   Huang, Yue ^b   Wang, Gang ^a   Chen, Sheng Di ^a,c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; COMPLEMENT FACTOR H; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; LATENT MEMBRANE PROTEIN 1; MICRORNA; MICRORNA 146; MICRORNA 146A; MICRORNA 146B; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; OCTAMER TRANSCRIPTION FACTOR 1; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 5Q; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; HUMAN; MONOCYTE; ONCOGENE C MYC; PATHOGENESIS; PROTEIN EXPRESSION; RNA BINDING; RNA STABILITY; RNA TRANSLATION; SIGNAL TRANSDUCTION; TEMPORAL CORTEX; TRANSCRIPTION REGULATION; UPREGULATION;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICRORNAS; MODELS, BIOLOGICAL; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84856450535     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.11.019     Document Type: Article

References (37)

1. Duyckaerts C., Delatour B., Potier M. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009, 118:5-36.
2. Morales I., Farias G., Maccioni R. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 2010, 17:202-204.
3. Boutajangout A., Quartermain D., Sigurdsson E. Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 2010, 30:16559-16566.
4. Jones L., Holmans P.A., Hamshere M.L., Harold D., Moskvina V., Ivanov D., et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010, 5:e13950.
5. Vollmar P., Kullmann J.S., Thilo B., Claussen M.C., Rothhammer V., Jacobi H., et al. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system. J Immunol 2010, 185:6338-6347.
6. Lu L.F., Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009, 127:291-298.
7. Xiao C., Rajewsky K. MicroRNA control in the immune system: basic principles. Cell 2009, 136:26-36.
8. Saba R., Goodman C., Huzarewich R.L., Robertson C., Booth S. A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3:e3652.
9. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008, 28:1213-1223.
10. Ponomarev E.D., Veremeyko T., Barteneva N., Krichevsky A.M., Weiner H.L. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU 1 pathway. Nat Med 2011, 17:64-70.
11. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146 an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006, 103:12481-12486.
12. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58:1284-1292.
13. Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., van Vliet E.A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010, 31:1100-1107.
14. Lukiw W.J., Zhao Y., Cui J.G. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 2008, 283:31315-31322.
15. Perry M.M., Williams A.E., Tsitsiou E., Larner-Svensson H.M., Lindsay M.A. Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 2009, 583:3349-3355.
16. Cameron J.E., Yin Q., Fewell C., Lacey M., McBride J., Wang X., et al. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 2008, 82:1946-1958.
17. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008, 40:43-50.
18. Sonkoly E., Wei T., Janson P.C., Saaf A., Lundeberg L., Tengvall-Linder M., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS One 2007, 2:e610.
19. Philippidou D., Schmitt M., Moser D., Margue C., Nazarov P.V., Muller A., et al. Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 2010, 70:4163-4173.
20. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
21. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
22. Li Y., Vandenboom T.G., Wang Z., Kong D., Ali S., Philip P.A., et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 2010, 70:1486-1495.
23. Mei J., Bachoo R., Zhang C. MicroRNA-146a Inhibits Glioma Development by Targeting Notch1. Mol Cell Biol 2011, 31:3584-3592.
24. Behrens M.I., Lendon C., Roe C.M., A common biological mechanism in cancer, Alzheimer's disease? Curr Alzheimer Res 2006, 6:196-204.
25. Roe C.M., Behrens M.I., Xiong C., Miller J.P., Morris J.C., Alzheimer disease, et al. Neurology 2005, 64:895-898.
26. Roe C.M., Fitzpatrick A.L., Xiong C., Sieh W., Kuller L., Miller J.P., et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010, 74:106-112.
27. Li Y.Y., Cui J.G., Hill J.M., Bhattacharjee S., Zhao Y., Lukiw W.J. Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett 2011, 487:94-98.
28. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009, 459:100-104.
29. Jin J.J., Kim H.D., Maxwell J.A., Li L., Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 2008, 5:23.
30. Tan L., Schedl P., Song H.J., Garza D., Konsolaki M. The Toll->NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PLoS One 2008, 3:e3966.
31. Cui J.G., Li Y.Y., Zhao Y., Bhattacharjee S., Lukiw W.J. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J Biol Chem 2010, 285:38951-38960.
32. Keating S.E., Maloney G.M., Moran E.M., Bowie A.G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 2007, 282:33435-33443.
33. Li Y.Y., Cui J.G., Dua P., Pogue A.I., Bhattacharjee S., Lukiw W.J. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett 2011, 499:109-113.
34. Xu D., Sharma C., Hemler M.E. Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 2009, 23:3674-3681.
35. Lederhuber H., Baer K., Altiok I., Sadeghi K., Herkner K.R., Kasper D.C. MicroRNA-146: tiny player in neonatal innate immunity?. Neonatology 2011, 99:51-56.
36. Zeng L., Liu J., Wang Y., Wang L., Weng S., Tang Y. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 2011, 3:1265-1272.
37. Redell J.B., Moore A.N., Ward N.H., Hergenroeder G.W., Dash P.K. Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma 2010, 27:2147-2156.